Cardiotoxicity Evaluation of Tyrosine Kinase Inhibition using Human Induced Pluripotent Stem Cell-derived Healthy and Long QT Syndrome Cardiomyocytes. (2024). Archives of Clinical and Biomedical Research, 8(2), 54-72. https://fortunejournals.org/ojs/index.php/acbr/article/view/15054